Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn

Showing results (111-120 of 240) with videos related to

Pageof 24
Sort By:
Breast Cancer Research and Treatment|February 2, 2019
Factors influencing the use of extended adjuvant endocrine therapyKunal C Kadakia, Kelley M Kidwell, Debra L Barton, et al.
Journal of AOAC International|July 20, 2017
Rapid Seafood Species Identification Using Chip-Based Capillary Electrophoresis and Protein Pattern MatchingCalvin C Walker, Cheryl L Lassitter, Shannara N Lynn, et al.
Pharmacogenetics and Genomics|February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptomsYuqing Liang, Christina L Gersch, Jennifer Lehman, et al.
Journal of the National Cancer Institute|March 15, 2014
Promoting quality and evidence-based care in early-stage breast cancer follow-upN Lynn Henry, Lynn N Henry, Daniel F Hayes, et al.
BMC Medical Research Methodology|November 10, 2021
Visualizing adverse events in clinical trials using correspondence analysis with R-package visaeMárcio A Diniz, Gillian Gresham, Sungjin Kim, et al.
Breast Cancer Research and Treatment|October 27, 2015
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitorKimberly Blackwell, Howard Burris, Patricia Gomez, et al.
Cancer|June 22, 2011
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptomsN Lynn Henry, Mousumi Banerjee, Max Wicha, et al.
Irish Journal of Medical Science|November 16, 2010
The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidismN Glynn, N Lynn, C Donagh, et al.
Methodsx|June 3, 2026
Flow cytometry method to identify arginase-1 expressing MDSCsPugazhendhi Srinivasan, Misty Bechtel, Dorota Wyczechowska, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' replyAustin Henry, James M Paik, Patrick Austin, et al.
Pageof 24

Showing results (111-120 of 240) with videos related to

Sort By:
Pageof 24
Breast Cancer Research and Treatment|February 2, 2019
Factors influencing the use of extended adjuvant endocrine therapyKunal C Kadakia, Kelley M Kidwell, Debra L Barton, et al.
Journal of AOAC International|July 20, 2017
Rapid Seafood Species Identification Using Chip-Based Capillary Electrophoresis and Protein Pattern MatchingCalvin C Walker, Cheryl L Lassitter, Shannara N Lynn, et al.
Pharmacogenetics and Genomics|February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptomsYuqing Liang, Christina L Gersch, Jennifer Lehman, et al.
Journal of the National Cancer Institute|March 15, 2014
Promoting quality and evidence-based care in early-stage breast cancer follow-upN Lynn Henry, Lynn N Henry, Daniel F Hayes, et al.
BMC Medical Research Methodology|November 10, 2021
Visualizing adverse events in clinical trials using correspondence analysis with R-package visaeMárcio A Diniz, Gillian Gresham, Sungjin Kim, et al.
Breast Cancer Research and Treatment|October 27, 2015
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitorKimberly Blackwell, Howard Burris, Patricia Gomez, et al.
Cancer|June 22, 2011
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptomsN Lynn Henry, Mousumi Banerjee, Max Wicha, et al.
Irish Journal of Medical Science|November 16, 2010
The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidismN Glynn, N Lynn, C Donagh, et al.
Methodsx|June 3, 2026
Flow cytometry method to identify arginase-1 expressing MDSCsPugazhendhi Srinivasan, Misty Bechtel, Dorota Wyczechowska, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' replyAustin Henry, James M Paik, Patrick Austin, et al.
Pageof 24